InnovAge press release (NASDAQ:INNV): Q4 GAAP EPS of -$0.01 beats by $0.01.
Revenue of $199.4M (+12.7% Y/Y) beats by $7.92M.
FY Revenue consensus of $849.62M
Full Fiscal Year 2025 Financial Guidance
Based on information as of today, September...
The company is benefiting from supplying the right kinds of businesses at the right time.
Energy and mining industry supplier Matrix Service (MTRX 15.32%) was a bright ball of energy on the stock exchange Tuesday. Its breaking news was...
The cost of equity is estimated to be 16% assuming: risk free rate 3.8%; equity risk premium 7%; beta 1.88. Discounting all the FCFE, the one-year target price is calculated to be $14 per share. Key Upside...
Relay Therapeutics (NASDAQ:RLAY) was upgraded by Jefferies but downgraded by Oppenheimer on Tuesday, the day after the shares rallied over 50% on positive data for its breast cancer drug candidate RLY-2608. Jefferies upgraded...
